Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2025-12-24 @ 5:54 PM
NCT ID:
NCT06168968
Eligibility Criteria:
Inclusion Criteria:
* Patients ≥18 years of age admitted with ACS, AIS, or multi-vessel CAD
* Competent mental condition to provide informed consent and able to participate in follow-ups
Exclusion Criteria:
* Pregnant women
* Currently enrolled in an investigational drug or device trial
* Undergoing treatment for neoplastic, autoimmune, or connective tissue disease
* COVID-19 infection within 30 days of enrollment
* Known history of hepatitis or HIV
* Deemed unfit to participate according to the investigator
* Known history of drug abuse
* Known platelet count of \<100,000/mm3
* Hematocrit \< 25%
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06168968
Study Brief:
Protocol Section:
NCT06168968